ALB and metabolic dysfunction-associated steatotic liver disease: Such key mediators of NAFLD as metabolism, reactive oxygen species, oxidative stress, and inflammation interfere with posttranslational modifications of ALB, which may partially explain why ALB binding function decreases earlier than other liver enzymes in NAFLD patients.